[Diagnosis of neurocysticercosis: a case report].
Neurocysticercosis is the most frequent parasitosis of central nervous system in the world. Neurological manifestations are in relation with locations number and topography, inflammatory reactions level and state of development of the parasite. Epilepsy is the main revealing symptom. Among other neurological manifestations, chronic headache, focal neurological signs, ataxia, language and behaviour disorder are the most anecdotal. The authors report a case of neurocysticercosis in a 71-year-old man with dysarthria and memory problems. Suspected by computed tomography, diagnosis was confirmed by immunoserologic assays such as enzyme-linked immunosorbent assay (ELISA) or enzyme-linked immunoelectrotransfer blot assay (EITB). This later emphasized on active form of the cyst. Specific treatment used albendazole as antihelminthic drug. Clinical evolution was good: neuroimaging and immunoserology results were normal respectively 2 and 6 months after the drug therapy.
Rajaonarison
P
P
Centre Hospitalier de Soavinandriana, BP 6 bis, 101 Antananarivo, Madagascar.
Ralamboson
S
S
Andriamamonjy
C
C
Ramanampamonjy
R
R
Ramanantoanina
C E
CE
Razafindratrimo
F
F
Villeneuve
R
R
Andriantsimahavandy
A
A
D000368:Aged; D015766:Albendazole / Q000627:therapeutic use; D000871:Anthelmintics / Q000627:therapeutic use; D004401:Dysarthria / Q000469:parasitology; D019353:Endemic Diseases; D004797:Enzyme-Linked Immunosorbent Assay; D004827:Epilepsy / Q000469:parasitology; D006801:Humans; D015151:Immunoblotting; D008270:Madagascar / Q000453:epidemiology; D008297:Male; D008569:Memory Disorders / Q000469:parasitology; D020019:Neurocysticercosis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000871:Anthelmintics; D015766:Albendazole